News
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...
The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...
It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication ...
The FDA on Wednesday approved a highly effective long-acting shot for HIV prevention that is administered just twice per year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback